Cocrystal Pharma Inc. (COCP)
NASDAQ · Healthcare
Cocrystal Pharma Inc. EBITDA 2011–2020
Cocrystal Pharma Inc. annual/quarterly ebitda history and growth rate from 2011 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Cocrystal Pharma Inc. ebitda for the quarter ending March 31, 2026 was -2.3 M, a 21.39% increase year-over-year.
- Cocrystal Pharma Inc. ebitda for the twelve months ending March 31, 2026 was -10.4 M, a 81.97% increase year-over-year.
- Cocrystal Pharma Inc. annual ebitda for 2020 was -9.4 M, a 80.48% decrease from 2019.
- Cocrystal Pharma Inc. annual ebitda for 2019 was -48.3 M, a 1339.81% increase from 2011.
- Cocrystal Pharma Inc. annual ebitda for 2011 was -3.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cocrystal Pharma Inc. EBITDA — FAQ
Cocrystal Pharma Inc. (COCP) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COCP's ebitda history?
The chart and table above show Cocrystal Pharma Inc.'s ebitda by year and by quarter, including the growth rate.